Next Generation Cancer Diagnostics Market: Innovation-Driven Growth and Future Opportunities According to a newly published market research report by 24LifeSciences, global next generation cancer diagnostics market was valued at USD 8,060 million in 2026 and is projected to reach USD 28,120 million by 2034, growing at a compound annual growth rate (CAGR) of 20.0% during the forecast period. Next generation cancer diagnostics represent a paradigm shift from traditional histopathology. These advanced technologies enable highly sensitive and specific analysis of cancer biomarkers from various biological samples, with key platforms including Next Generation Sequencing (NGS), qPCR & Multiplexing, and DNA Microarrays. These tools are fundamental for applications such as early detection, companion diagnostics, treatment selection, and minimal residual disease monitoring, enabling a more precise and personalized approach to oncology. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8895/next-generation-cancer-diagnostics-market